Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 535434 | NSE Symbol : MADHAVBAUG | ISIN : INE0JR301013 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
18-Feb-2025	18-Feb-2025	Forfeiture of Shares	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on February 18, 2025.
13-Feb-2025	13-Feb-2025	Change in Directors	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on February 13, 2025.
20-Dec-2024	20-Dec-2024	Change in Other Executives	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on December 20, 2024. has interalia, approved the following:Resignation of Mr. Shripad Upasani as Chief Executive Officer (Key Managerial Personnel), witheffect from the closure of working hours of 20th December, 2024.
06-Dec-2024	06-Dec-2024	Preferential Issue	With reference to the captioned subject and in accordance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform your good office that the Audit Committee of the Board of Directors of the Company in their meeting held on Friday, 06th December, 2024 has, inter alia, considered the Lapsing of 5,00,000 (Five Lakhs) Fully Convertible Warrants('Warrants') on 27th November 2024, due to nonexercised of option to convert warrants into equity shares within the stipulated eighteen-month period from the date of allotment.
29-Oct-2024	11-Nov-2024	Quarterly Results	To consider and approve the financial results for the period ended September 30, 2024 and other business matters Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on November 11, 2024. (As Per NSE Announcement Dated on: 11/11/2024)
06-Sep-2024	06-Sep-2024	AGM	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on September 06, 2024.
13-Aug-2024	13-Aug-2024	Change in Other Executives	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on August 13, 2024.
20-May-2024	26-May-2024	Quarterly Results	To consider and approve the financial results for the period ended March 31, 2024 and other business matters Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board meeting held on May 26, 2024. (As Per NSE Announcement Dated on: 26/05/2024)
07-Nov-2023	14-Nov-2023	Half Yearly Results	To consider and approve the financial results for the period ended September 30, 2023 and other business matters Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on November 14, 2023. inter alia considered and approved Un audited financial results for half year ended 30th Sept 2023 (As Per NSE Announcement Dated on: 14/11/2023)
31-Aug-2023	31-Aug-2023	Change in Directors	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board meeting held on August 31, 2023
09-Aug-2023	14-Aug-2023	AGM	To consider and approve inter-alia allotment of Share warrants to Non Promoter Group and any other business matter VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to consider Other business. (As Per NSE Announcement Dated on 09/08/2023) Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board meeting held on August 14, 2023. (As Per NSE Announcement Dated on 14/08/2023)
06-Jul-2023	11-Jul-2023	Others	To consider Fund Raising and other business matters VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Jul-2023 to consider and approve Fund raising/Dividend/Other business. (As Per NSE Announcement Dated on 10/07/2023) VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Jul-2023 to consider and approve Fund raising/Other business. Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board of Directors in its meeting dated July 11, 2023 inter-alia considered and approved Fund raising through preferential issue of share warrants to strategic Investors subject to approval of members (As Per NSE Announcement Dated on 11/07/2023)
18-May-2023	27-May-2023	Accounts	To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board of Directors has recommended Rs. 0.25 per share as final dividend for year ended 31st March 2023 Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding 'Audited Financial Results for year ended 31st March 2023'. Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding outcome of Board meeting held on May 27, 2023. (As Per NSE Announcement Dated on 27/05/2023) Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Copy of Newspaper Publication (As Per NSE Announcement Dated on 28/05/2023) Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. (As Per NSE Announcement Dated on 29/05/2023) VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 27-May-2023 for Dividend (As Per NSE Announcement Dated on 30/05/2023) The Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. (As Per NSE Announcement Dated on 04/07/2023)
15-Mar-2023	23-Mar-2023	Preferential Issue	To consider Fund Raising through Share Warrants convertible into Equity Shares through Preferential Allotment to Promoters or Non-promoter and other business matters Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Board meeting held on March 23, 2023, inter alia consider and approved to issue 5,00,000 share warrants convertible into equity shares on preferential basis at Rs. 219.03/- to Promoters & its promoter group company (As Per NSE Announcement Dated on 23/03/2023)
02-Nov-2022	10-Nov-2022	Quarterly Results	Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2022 to consider Unaudited Standalone and Consolidated financial results for the period ended 30th September 2022 and to consider Interim Dividend. In the event of Interim dividend if declared by the Board, the record date pursuant to Regulations 42 of the SEBI Regulations will be Friday, November 18, 2022, for the purpose of ascertaining the eligibility of the shareholders for payment of Interim Dividend for the FY 2022-23. Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board Meeting held on 10-Nov-2022 to consider financial statements for the period ended September 2022, Dividend and Other business matters Vaidya Sane Ayurved Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on 10-Nov-2022, declared Dividend of Rs. 0.25 per equity share. (As Per NSE Announcement Dated on 10.11.2022)

1 2

LOGIN HERE

Vaidya Sane Ayurved Laboratories Ltd

Board Meeting